Closing Bell: Briacell Therapeutics Corp down on Monday (BCT)

Briacell Therapeutics Corp opened trading today at $1.04 and closed at $0.93. prices ranged from $0.86 to $1.04.

The price shrank -18.42% from the previous day's close of $1.14.

Today across North America, the TSX Composite closed 0.80% at 22872.65, the S&P 500 closed -0.71% at 5505.00, the Dow Jones Industrial Average closed -0.93% at 40287.53 and the Nasdaq Composite closed -0.81% at 17726.94.

Briacell Therapeutics Corp has listed on the Toronto Stock Exchange (TSX) under the ticker BCT.

Trading volume was 143,728 on 188 total trades. On average, Briacell Therapeutics Corp has traded 61,962 shares over 5 days and 10,243 year-to-date.

Trading across the entire TSX saw 3,734 price advancers against 1,480 declines and 101 unchanged.

During the prior 52 weeks, BCT.TO has traded as high as $10.29 (August 28,2023) and low as $0.86 (July 22,2024). Moreover, the shares have shrunken -88.97 percent in the last 12 months, while they have plummeted -88.08% year-to-date.

Following today's trading, Briacell Therapeutics Corp has a market capitalization of $20.84 million on a float of 18,285 shares outstanding. Its annual EPS is $-0.37.

Briacell Therapeutics Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Based on 1.00 analysts, Briacell Therapeutics Corp gets an average recommendation of "Strong Buy" according to Zacks. From those 1 analysts, 1 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..